HbA1c検査機器の世界市場の評価：機器タイプ別、技術別、エンドユーザー別、地域別、機会、予測（2017年～2031年）

世界のHbA1c検査機器の市場規模は、2023年の23億7,200万米ドルから2031年に42億3,356万米ドルに達すると予測され、予測期間の2024年～2031年にCAGRで7.51%の成長が見込まれます。HbA1c検査機器の市場需要は、糖尿病の有病率の増加、投資家や市場企業の関心の高まりにより、予測年間に飛躍的に成長する見込みです。

市場は、世界中で糖尿病が急速に広がっているため多くの成長機会を示しています。糖尿病の症例、特に2型糖尿病の症例が多く報告されており、人々はこの疾患の効果的な定期モニタリングを求めています。そのため、HbA1c検査は、ポイントオブケア検査機器などの技術的進歩を含め、長期的な血糖値を測定する必需品となっています。糖尿病の有病率は中低所得国で非常に高いです。実際、罹患者の約4分の3が中低所得国に居住しています。糖尿病は、体内でインスリンが生成されないか、あるいは効果的に使用されないことから生じる慢性疾患です。その結果、体内の血糖値が上昇し、心血管疾患、腎疾患、視力障害など、さらに深刻な合併症を引き起こします。4億2,200万人を超える人々が糖尿病に苦しんでおり、その大多数が低中所得国に住んでいます。このうち、毎年約150万人が糖尿病が原因で死亡しています。例えば2024年2月、HemoCueは低中所得国における1型糖尿病の小児に対するポイントオブケア診断検査を向上させるための、Novo Nordisk A/Sとの提携を発表しました。

当レポートでは、世界のHbA1c検査機器市場について調査分析し、市場規模と予測、市場力学、主要企業の情勢などを提供しています。

目次

第1章 プロジェクトの範囲と定義

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 世界のHbA1c検査機器市場の見通し（2017年～2031年）

• 市場規模の分析と予測
  • 金額
• 市場シェアの分析と予測
  • 機器タイプ別
  • 技術別
  • エンドユーザー別
  • 地域別
  • 市場シェア分析：企業別（金額）（上位5社とその他 - 2023年）
• 市場マップ分析（2023年）
  • 機器タイプ別
  • 技術別
  • エンドユーザー別
  • 地域別

第5章 北米のHbA1c検査機器市場の見通し（2017年～2031年）

• 市場規模の分析と予測
  • 金額
• 市場シェアの分析と予測
  • 機器タイプ別
  • 技術別
  • エンドユーザー別
  • シェア：国別
• 各国の市場の評価
  • 米国のHbA1c検査機器市場の見通し（2017年～2031年）
  • カナダ
  • メキシコ

第6章 欧州のHbA1c検査機器市場の見通し（2017年～2031年）

• ドイツ
• フランス
• イタリア
• 英国
• ロシア
• オランダ
• スペイン
• ポーランド

第7章 アジア太平洋のHbA1c検査機器市場の見通し（2017年～2031年）

• インド
• 中国
• 日本
• オーストラリア
• ベトナム
• 韓国
• インドネシア
• フィリピン

第8章 南米のHbA1c検査機器市場の見通し（2017年～2031年）

• ブラジル
• アルゼンチン

第9章 中東・アフリカのHbA1c検査機器市場の見通し（2017年～2031年）

• サウジアラビア
• アラブ首長国連邦
• 南アフリカ
• イスラエル

第10章 需給分析

第11章 バリューチェーン分析

第12章 ポーターのファイブフォース分析

第13章 PESTLE分析

第14章 市場力学

• 市場促進要因
• 市場の課題

第15章 市場の動向と発展

第16章 規制枠組みとイノベーション

• 規制当局の承認
• イノベーション

第17章 特許情勢

第18章 ケーススタディ

第19章 競合情勢

• マーケットリーダー上位5社の競合マトリクス
• 上位5社のSWOT分析
• 主要企業上位10社の情勢
  • Abbott.
  • Bio-Rad Laboratories, Inc.
  • Trinity Biotech
  • Siemens Healthineers AG
  • F.Hoffmann-La Roche Ltd
  • Danaher Corporation
  • SAKAE CO, LTD.
  • ARKRAY, Inc.
  • HUMAN Gesellschaft fur Biochemica und Diagnostica
  • Menarini Diagnostics s.r.l

第20章 戦略的推奨

第21章 当社について、免責事項

List of Tables

• Table 1. Pricing Analysis of Products from Key Players
• Table 2. Competition Matrix of Top 5 Market Leaders
• Table 3. Mergers & Acquisitions/ Joint Ventures (If Applicable)
• Table 4. About Us - Regions and Countries Where We Have Executed Client Projects

List of Figures

• Figure 1. Global HbA1c Testing Devices Market, By Value, In USD Million, 2017-2031F
• Figure 2. Global HbA1c Testing Devices Market Share (%), By Type of Devices, 2017-2031F
• Figure 3. Global HbA1c Testing Devices Market Share (%), By Technology, 2017-2031F
• Figure 4. Global HbA1c Testing Devices Market Share (%), By End-user, 2017-2031F
• Figure 5. Global HbA1c Testing Devices Market Share (%), By Region, 2017-2031F
• Figure 6. North America HbA1c Testing Devices Market, By Value, In USD Million, 2017-2031F
• Figure 7. North America HbA1c Testing Devices Market Share (%), By Type of Devices, 2017-2031F
• Figure 8. North America HbA1c Testing Devices Market Share (%), By Technology, 2017-2031F
• Figure 9. North America HbA1c Testing Devices Market Share (%), By End-user, 2017-2031F
• Figure 10. North America HbA1c Testing Devices Market Share (%), By Country, 2017-2031F
• Figure 11. United States HbA1c Testing Devices Market, By Value, In USD Million, 2017-2031F
• Figure 12. United States HbA1c Testing Devices Market Share (%), By Type of Devices, 2017-2031F
• Figure 13. United States HbA1c Testing Devices Market Share (%), By Technology, 2017-2031F
• Figure 14. United States HbA1c Testing Devices Market Share (%), By End-user, 2017-2031F
• Figure 15. Canada HbA1c Testing Devices Market, By Value, In USD Million, 2017-2031F
• Figure 16. Canada HbA1c Testing Devices Market Share (%), By Type of Devices, 2017-2031F
• Figure 17. Canada HbA1c Testing Devices Market Share (%), By Technology, 2017-2031F
• Figure 18. Canada HbA1c Testing Devices Market Share (%), By End-user, 2017-2031F
• Figure 19. Mexico HbA1c Testing Devices Market, By Value, In USD Million, 2017-2031F
• Figure 20. Mexico HbA1c Testing Devices Market Share (%), By Type of Devices, 2017-2031F
• Figure 21. Mexico HbA1c Testing Devices Market Share (%), By Technology, 2017-2031F
• Figure 22. Mexico HbA1c Testing Devices Market Share (%), By End-user, 2017-2031F
• Figure 23. Europe HbA1c Testing Devices Market, By Value, In USD Million, 2017-2031F
• Figure 24. Europe HbA1c Testing Devices Market Share (%), By Type of Devices, 2017-2031F
• Figure 25. Europe HbA1c Testing Devices Market Share (%), By Technology, 2017-2031F
• Figure 26. Europe HbA1c Testing Devices Market Share (%), By End-user, 2017-2031F
• Figure 27. Europe HbA1c Testing Devices Market Share (%), By Country, 2017-2031F
• Figure 28. Germany HbA1c Testing Devices Market, By Value, In USD Million, 2017-2031F
• Figure 29. Germany HbA1c Testing Devices Market Share (%), By Type of Devices, 2017-2031F
• Figure 30. Germany HbA1c Testing Devices Market Share (%), By Technology, 2017-2031F
• Figure 31. Germany HbA1c Testing Devices Market Share (%), By End-user, 2017-2031F
• Figure 32. France HbA1c Testing Devices Market, By Value, In USD Million, 2017-2031F
• Figure 33. France HbA1c Testing Devices Market Share (%), By Type of Devices, 2017-2031F
• Figure 34. France HbA1c Testing Devices Market Share (%), By Technology, 2017-2031F
• Figure 35. France HbA1c Testing Devices Market Share (%), By End-user, 2017-2031F
• Figure 36. Italy HbA1c Testing Devices Market, By Value, In USD Million, 2017-2031F
• Figure 37. Italy HbA1c Testing Devices Market Share (%), By Type of Devices, 2017-2031F
• Figure 38. Italy HbA1c Testing Devices Market Share (%), By Technology, 2017-2031F
• Figure 39. Italy HbA1c Testing Devices Market Share (%), By End-user, 2017-2031F
• Figure 40. United Kingdom HbA1c Testing Devices Market, By Value, In USD Million, 2017-2031F
• Figure 41. United Kingdom HbA1c Testing Devices Market Share (%), By Type of Devices, 2017-2031F
• Figure 42. United Kingdom HbA1c Testing Devices Market Share (%), By Technology, 2017-2031F
• Figure 43. United Kingdom HbA1c Testing Devices Market Share (%), By End-user, 2017-2031F
• Figure 44. Russia HbA1c Testing Devices Market, By Value, In USD Million, 2017-2031F
• Figure 45. Russia HbA1c Testing Devices Market Share (%), By Type of Devices, 2017-2031F
• Figure 46. Russia HbA1c Testing Devices Market Share (%), By Technology, 2017-2031F
• Figure 47. Russia HbA1c Testing Devices Market Share (%), By End-user, 2017-2031F
• Figure 48. Netherlands HbA1c Testing Devices Market, By Value, In USD Million, 2017-2031F
• Figure 49. Netherlands HbA1c Testing Devices Market Share (%), By Type of Devices, 2017-2031F
• Figure 50. Netherlands HbA1c Testing Devices Market Share (%), By Technology, 2017-2031F
• Figure 51. Netherlands HbA1c Testing Devices Market Share (%), By End-user, 2017-2031F
• Figure 52. Spain HbA1c Testing Devices Market, By Value, In USD Million, 2017-2031F
• Figure 53. Spain HbA1c Testing Devices Market Share (%), By Type of Devices, 2017-2031F
• Figure 54. Spain HbA1c Testing Devices Market Share (%), By Technology, 2017-2031F
• Figure 55. Spain HbA1c Testing Devices Market Share (%), By End-user, 2017-2031F
• Figure 56. Turkey HbA1c Testing Devices Market, By Value, In USD Million, 2017-2031F
• Figure 57. Turkey HbA1c Testing Devices Market Share (%), By Type of Devices, 2017-2031F
• Figure 58. Turkey HbA1c Testing Devices Market Share (%), By Technology, 2017-2031F
• Figure 59. Turkey HbA1c Testing Devices Market Share (%), By End-user, 2017-2031F
• Figure 60. Poland HbA1c Testing Devices Market, By Value, In USD Million, 2017-2031F
• Figure 61. Poland HbA1c Testing Devices Market Share (%), By Type of Devices, 2017-2031F
• Figure 62. Poland HbA1c Testing Devices Market Share (%), By Technology, 2017-2031F
• Figure 63. Poland HbA1c Testing Devices Market Share (%), By End-user, 2017-2031F
• Figure 64. South America HbA1c Testing Devices Market, By Value, In USD Million, 2017-2031F
• Figure 65. South America HbA1c Testing Devices Market Share (%), By Type of Devices, 2017-2031F
• Figure 66. South America HbA1c Testing Devices Market Share (%), By Technology, 2017-2031F
• Figure 67. South America HbA1c Testing Devices Market Share (%), By End-user, 2017-2031F
• Figure 68. South America HbA1c Testing Devices Market Share (%), By Country, 2017-2031F
• Figure 69. Brazil HbA1c Testing Devices Market, By Value, In USD Million, 2017-2031F
• Figure 70. Brazil HbA1c Testing Devices Market Share (%), By Type of Devices, 2017-2031F
• Figure 71. Brazil HbA1c Testing Devices Market Share (%), By Technology, 2017-2031F
• Figure 72. Brazil HbA1c Testing Devices Market Share (%), By End-user, 2017-2031F
• Figure 73. Argentina HbA1c Testing Devices Market, By Value, In USD Million, 2017-2031F
• Figure 74. Argentina HbA1c Testing Devices Market Share (%), By Type of Devices, 2017-2031F
• Figure 75. Argentina HbA1c Testing Devices Market Share (%), By Technology, 2017-2031F
• Figure 76. Argentina HbA1c Testing Devices Market Share (%), By End-user, 2017-2031F
• Figure 77. Asia-Pacific HbA1c Testing Devices Market, By Value, In USD Million, 2017-2031F
• Figure 78. Asia-Pacific HbA1c Testing Devices Market Share (%), By Type of Devices, 2017-2031F
• Figure 79. Asia-Pacific HbA1c Testing Devices Market Share (%), By Technology, 2017-2031F
• Figure 80. Asia-Pacific HbA1c Testing Devices Market Share (%), By End-user, 2017-2031F
• Figure 81. Asia-Pacific HbA1c Testing Devices Market Share (%), By Country, 2017-2031F
• Figure 82. India HbA1c Testing Devices Market, By Value, In USD Million, 2017-2031F
• Figure 83. India HbA1c Testing Devices Market Share (%), By Type of Devices, 2017-2031F
• Figure 84. India HbA1c Testing Devices Market Share (%), By Technology, 2017-2031F
• Figure 85. India HbA1c Testing Devices Market Share (%), By End-user, 2017-2031F
• Figure 86. China HbA1c Testing Devices Market, By Value, In USD Million, 2017-2031F
• Figure 87. China HbA1c Testing Devices Market Share (%), By Type of Devices, 2017-2031F
• Figure 88. China HbA1c Testing Devices Market Share (%), By Technology, 2017-2031F
• Figure 89. China HbA1c Testing Devices Market Share (%), By End-user, 2017-2031F
• Figure 90. Japan HbA1c Testing Devices Market, By Value, In USD Million, 2017-2031F
• Figure 91. Japan HbA1c Testing Devices Market Share (%), By Type of Devices, 2017-2031F
• Figure 92. Japan HbA1c Testing Devices Market Share (%), By Technology, 2017-2031F
• Figure 93. Japan HbA1c Testing Devices Market Share (%), By End-user, 2017-2031F
• Figure 94. Australia HbA1c Testing Devices Market, By Value, In USD Million, 2017-2031F
• Figure 95. Australia HbA1c Testing Devices Market Share (%), By Type of Devices, 2017-2031F
• Figure 96. Australia HbA1c Testing Devices Market Share (%), By Technology, 2017-2031F
• Figure 97. Australia HbA1c Testing Devices Market Share (%), By End-user, 2017-2031F
• Figure 98. Vietnam HbA1c Testing Devices Market, By Value, In USD Million, 2017-2031F
• Figure 99. Vietnam HbA1c Testing Devices Market Share (%), By Type of Devices, 2017-2031F
• Figure 100. Vietnam HbA1c Testing Devices Market Share (%), By Technology, 2017-2031F
• Figure 101. Vietnam HbA1c Testing Devices Market Share (%), By End-user, 2017-2031F
• Figure 102. South Korea HbA1c Testing Devices Market, By Value, In USD Million, 2017-2031F
• Figure 103. South Korea HbA1c Testing Devices Market Share (%), By Type of Devices, 2017-2031F
• Figure 104. South Korea HbA1c Testing Devices Market Share (%), By Technology, 2017-2031F
• Figure 105. South Korea HbA1c Testing Devices Market Share (%), By End-user, 2017-2031F
• Figure 106. Indonesia HbA1c Testing Devices Market, By Value, In USD Million, 2017-2031F
• Figure 107. Indonesia HbA1c Testing Devices Market Share (%), By Type of Devices, 2017-2031F
• Figure 108. Indonesia HbA1c Testing Devices Market Share (%), By Technology, 2017-2031F
• Figure 109. Indonesia HbA1c Testing Devices Market Share (%), By End-user, 2017-2031F
• Figure 110. Philippines HbA1c Testing Devices Market, By Value, In USD Million, 2017-2031F
• Figure 111. Philippines HbA1c Testing Devices Market Share (%), By Type of Devices, 2017-2031F
• Figure 112. Philippines HbA1c Testing Devices Market Share (%), By Technology, 2017-2031F
• Figure 113. Philippines HbA1c Testing Devices Market Share (%), By End-user, 2017-2031F
• Figure 114. Middle East & Africa HbA1c Testing Devices Market, By Value, In USD Million, 2017-2031F
• Figure 115. Middle East & Africa HbA1c Testing Devices Market Share (%), By Type of Devices, 2017-2031F
• Figure 116. Middle East & Africa HbA1c Testing Devices Market Share (%), By Technology, 2017-2031F
• Figure 117. Middle East & Africa HbA1c Testing Devices Market Share (%), By End-user, 2017-2031F
• Figure 118. Middle East & Africa HbA1c Testing Devices Market Share (%), By Country, 2017-2031F
• Figure 119. Saudi Arabia HbA1c Testing Devices Market, By Value, In USD Million, 2017-2031F
• Figure 120. Saudi Arabia HbA1c Testing Devices Market Share (%), By Type of Devices, 2017-2031F
• Figure 121. Saudi Arabia HbA1c Testing Devices Market Share (%), By Technology, 2017-2031F
• Figure 122. Saudi Arabia HbA1c Testing Devices Market Share (%), By End-user, 2017-2031F
• Figure 123. UAE HbA1c Testing Devices Market, By Value, In USD Million, 2017-2031F
• Figure 124. UAE HbA1c Testing Devices Market Share (%), By Type of Devices, 2017-2031F
• Figure 125. UAE HbA1c Testing Devices Market Share (%), By Technology, 2017-2031F
• Figure 126. UAE HbA1c Testing Devices Market Share (%), By End-user, 2017-2031F
• Figure 127. South Africa HbA1c Testing Devices Market, By Value, In USD Million, 2017-2031F
• Figure 128. South Africa HbA1c Testing Devices Market Share (%), By Type of Devices, 2017-2031F
• Figure 129. South Africa HbA1c Testing Devices Market Share (%), By Technology, 2017-2031F
• Figure 130. South Africa HbA1c Testing Devices Market Share (%), By End-user, 2017-2031F
• Figure 131. By Type of Devices Map-Market Size (USD Million) & Growth Rate (%), 2023
• Figure 132. By Technology Map-Market Size (USD Million) & Growth Rate (%), 2023
• Figure 133. By End-user Map-Market Size (USD Million) & Growth Rate (%), 2023
• Figure 134. By Region Map-Market Size (USD Million) & Growth Rate (%), 2023

Global HbA1c testing devices market is projected to witness a CAGR of 7.51% during the forecast period 2024-2031, growing from USD 2372 million in 2023 to USD 4233.56 million in 2031. The market demand for HbA1c testing devices is anticipated to thrive drastically in the forecast years due to the increasing prevalence of diabetes and the growing interest of investors and market players.

The global HbA1c testing device market is thus witnessing many growth opportunities due to the fast spreading of diabetes across the globe. More cases of diabetes are being reported, especially type 2 cases, for which people look for effective and regular monitoring for this disease. Thus, HbA1c testing becomes a necessity-measuring long-term blood glucose levels, including technological advancements such as point-of-care testing devices. The prevalence of diabetes is very high in low- and middle-income countries. In fact, about three-quarters of the affected people reside in low- and middle-income countries. Diabetes is a chronic condition that results from a lack of production or ineffective use of insulin by the body. As a result, the blood glucose level (blood sugar level) increases in the body, which leads to even more severe complications such as cardiovascular diseases, kidney disease, and vision problems. More than 422 million people suffer from diabetes, of which a vast majority live in low- and middle-income countries. Out of these, around 1.5 million die each year due to diabetes. For instance, in February 2024, HemoCue announced a partnership with Novo Nordisk A/S to improve point-of-care diagnostic testing for children with type 1 diabetes in low- and middle-income countries.

Increased Prevalence of Diabetes to Support HbA1c Testing Devices Market Growth

The increasing incidence of diabetes is driving the market for HbA1c testing devices. Rising burdens, especially due to changing lifestyle, aging population, and increasing obesity rates, have spurred demand for adequate management tools for diabetes. The HbA1c testing device measures blood glucose levels over the long term to evaluate the efficiency of a treatment regime and the potential risks of complications. As the number of diabetes patients increases, healthcare providers rely more on these tests for routine diabetes care to advance diabetes management. The devices have become necessary for having steady and accurate monitoring in clinical and home settings, driving better outcomes for patients and better management of the disease at large. For instance, in April 2023, FIND announced a partnership with Abbott, i-SENS, Inc., and Siemens Healthineers AG to improve hemoglobin (HbA1c) testing for diabetes diagnosis and management by offering a special price for point-of-care test kits for low and middle-income countries (LMICs).

Technological Advancement in Testing Devices to Drive Market Growth

Advancements in the technology of devices used for HbA1c testing have played a significant role in the growth of this market. Technological advancements have made the tests more accurate and convenient to access. Innovations such as point-of-care (POC) devices have allowed testing outside traditional laboratories, which could provide immediate results in minutes. Portable analyzers that are friendly to the user have made it easier for healthcare providers to monitor the glycemic control of their patients in real time and improve their decisions based on clinical judgment. Furthermore, developing automated systems and integrated platforms with HbA1c testing that integrate with other diagnostic procedures helps streamline the procedure and reduce the number of visits to the healthcare provider to conduct the test. Such advancements improve patient outcomes by making regular HbA1c monitoring available, even in hard-to-reach or underserved areas, and support increased demand for personalized diabetes management. For instance, in July 2024, EKF Diagnostics Holdings plc, a global diagnostics business, announced the launch of its new Biosen C-Line, an advanced version of its industry-leading rapid benchtop glucose and lactate analyzer. The Biosen C-Line analyzer measures glucose and lactate levels in whole blood, plasma, and serum using enzymatic sensor technology to give precise results.

Point-of-Care Testing Devices Segment to Dominate the HbA1c Testing Devices Market Share

The point-of-care (POC) testing devices segment is anticipated to dominate the market of HbA1c testing devices primarily due to the rising demand for fast, accessible, and reliable diabetic management solutions. POC testing devices enable one to carry out HbA1c testing on-site and thereby provide healthcare providers and patients with real-time information in various settings, such as clinics, pharmacies, and home settings. This gives an opportunity for the modification of treatment plans in a timely manner, thus providing better patient outcomes and satisfaction. With patients continuously getting affected with diabetes around the globe, POC testing devices will play an important role in the effective management of diabetes and hence prove to be a big growth driver in the HbA1c testing device market. For instance, in December 2023, F. Hoffmann-La Roche Ltd signed a deal to acquire LumiraDx point-of-care testing technology for USD 295 million, with an extra USD 55 million committed to supporting Lumira's platform development until the acquisition is finalized.

North America to Dominate the HbA1c Testing Devices Market Share

North America leads the share of the global HbA1c testing devices market due to the high prevalence of diabetes, higher healthcare expenditure, and advanced healthcare infrastructure in the region. Driving factors behind this region's growth are strong awareness of diabetes management, early adoption of advanced diagnostic technologies, and a well-established healthcare system. Moreover, a growing obese population and an aging population also require more HbA1c tests because the control of this condition requires timely monitoring of blood glucose levels. So, North America leads the HbA1c testing device market due to these technological innovations and strategic tie-ups by the key players in this industry. For instance, in June 2024, Abbott announced receiving approval from the U.S. Food and Drug Administration (FDA) for two new over-the-counter continuous glucose monitoring (CGM) systems, Lingo and Libre Rio. Lingo targets general consumers focused on improving overall health and wellness. Libre Rio is tailored for adults with Type 2 diabetes who manage their condition through lifestyle changes and do not use insulin.

Future Market Scenario (2024-2031F)

The HbA1c testing device market is expected to grow significantly in the future because of a continuously increasing rate of diabetes across the globe, increased focus on preventive care, and new developments in diagnostic technology. A better understanding and higher adoption rate of point-of-care devices will drive demand. The high ease of use, greater accuracy in testing, and compatibility with digital health platforms for the management of diseases will allow for greater ease of accessibility and patient engagement in the market. In particular, emerging economies with expanding healthcare infrastructure and increased healthcare spending will provide significant market opportunities. Overall, the market is likely to expand due to continuous R&D, strategic alliances, and regulatory approvals to improve diabetes monitoring and patient outcomes. For instance, in December 2023, Tosoh Bioscience partnership with Sysmex Corporation America to connect its HLC-723G8 automated glycohemoglobin analyzers with Sysmex's XN-9000 and XN-9100 hematology systems across the U.S., Latin America, and Canada. This collaboration aims to expand Tosoh's HbA1c testing capabilities for high-volume labs and enhance automation in HbA1c testing.

Key Players Landscape and Outlook

The HbA1c testing devices market is highly dynamic and driven by many key market players. Market activity reported in recent years includes business agreements and regulatory approvals of market players' products. The market has witnessed many business activities, such as strategic mergers, acquisitions, and collaborations.

For instance, in February 2024, Dexcom, Inc. launched Dexcom ONE+ in Spain, Belgium, and Poland-a customizable, real-time continuous glucose monitoring (CGM) system solution wearable in three body locations. The Dexcom ONE+ system includes a water-resistant sensor, a transmitter for real-time glucose data, and a smartphone-compatible app for convenient monitoring.

Table of Contents

1. Project Scope and Definitions

2. Research Methodology

3. Executive Summary

4. Global HbA1c Testing Devices Market Outlook, 2017-2031F

• 4.1. Market Size Analysis & Forecast
  • 4.1.1. By Value
• 4.2. Market Share Analysis & Forecast
  • 4.2.1. By Type of Devices
    • 4.2.1.1. Laboratory-based Testing Devices
    • 4.2.1.2. Point-of-Care Testing Devices
  • 4.2.2. By Technology
    • 4.2.2.1. Immunoassay
    • 4.2.2.2. Enzymatic Assays
    • 4.2.2.3. Chromatography
    • 4.2.2.4. High-performance Liquid Chromatography
    • 4.2.2.5. Boronate Affinity Chromatography
    • 4.2.2.6. Others
  • 4.2.3. By End-user
    • 4.2.3.1. Hospitals and Clinics
    • 4.2.3.2. Diagnostic Laboratories
    • 4.2.3.3. Homecare Settings
    • 4.2.3.4. Others
  • 4.2.4. By Region
    • 4.2.4.1. North America
    • 4.2.4.2. Europe
    • 4.2.4.3. Asia-Pacific
    • 4.2.4.4. South America
    • 4.2.4.5. Middle East and Africa
  • 4.2.5. By Company Market Share Analysis (Top 5 Companies and Others - By Value, 2023)
• 4.3. Market Map Analysis, 2023
  • 4.3.1. By Type of Devices
  • 4.3.2. By Technology
  • 4.3.3. By End-user
  • 4.3.4. By Region

5. North HbA1c Testing Devices Market Outlook, 2017-2031F*

• 5.1. Market Size Analysis & Forecast
  • 5.1.1. By Value
• 5.2. Market Share Analysis & Forecast
  • 5.2.1. By Type of Devices
    • 5.2.1.1. Laboratory-based Testing Devices
    • 5.2.1.2. Point-of-Care Testing Devices
  • 5.2.2. By Technology
    • 5.2.2.1. Immunoassay
    • 5.2.2.2. Enzymatic Assays
    • 5.2.2.3. Chromatography
    • 5.2.2.4. High-performance Liquid Chromatography
    • 5.2.2.5. Boronate Affinity Chromatography
    • 5.2.2.6. Others
  • 5.2.3. By End-user
    • 5.2.3.1. Hospitals and Clinics
    • 5.2.3.2. Diagnostic Laboratories
    • 5.2.3.3. Homecare Settings
    • 5.2.3.4. Others
  • 5.2.4. By Country Share
    • 5.2.4.1. United States
    • 5.2.4.2. Canada
    • 5.2.4.3. Mexico
• 5.3. Country Market Assessment
  • 5.3.1. United States HbA1c Testing Devices Market Outlook, 2017-2031F*
    • 5.3.1.1. Market Size Analysis & Forecast
      • 5.3.1.1.1. By Value
    • 5.3.1.2. Market Share Analysis & Forecast
      • 5.3.1.2.1. By Type of Devices
        • 5.3.1.2.1.1. Laboratory-based Testing Devices
        • 5.3.1.2.1.2. Point-of-Care Testing Devices
      • 5.3.1.2.2. By Technology
        • 5.3.1.2.2.1. Immunoassay
        • 5.3.1.2.2.2. Enzymatic Assays
        • 5.3.1.2.2.3. Chromatography
        • 5.3.1.2.2.4. High-performance Liquid Chromatography
        • 5.3.1.2.2.5. Boronate Affinity Chromatography
        • 5.3.1.2.2.6. Others
      • 5.3.1.2.3. By End-user
        • 5.3.1.2.3.1. Hospitals and Clinics
        • 5.3.1.2.3.2. Diagnostic Laboratories
        • 5.3.1.2.3.3. Homecare Settings
        • 5.3.1.2.3.4. Others
  • 5.3.2. Canada
  • 5.3.3. Mexico

All segments will be provided for all regions and countries covered

6. Europe HbA1c Testing Devices Market Outlook, 2017-2031F

• 6.1. Germany
• 6.2. France
• 6.3. Italy
• 6.4. United Kingdom
• 6.5. Russia
• 6.6. Netherlands
• 6.7. Spain
• 6.8. Poland

7. Asia-Pacific HbA1c Testing Devices Market Outlook, 2017-2031F

• 7.1. India
• 7.2. China
• 7.3. Japan
• 7.4. Australia
• 7.5. Vietnam
• 7.6. South Korea
• 7.7. Indonesia
• 7.8. Philippines

8. South America HbA1c Testing Devices Market Outlook, 2017-2031F

• 8.1. Brazil
• 8.2. Argentina

9. Middle East and Africa HbA1c Testing Devices Market Outlook, 2017-2031F

• 9.1. Saudi Arabia
• 9.2. UAE
• 9.3. South Africa
• 9.4. Israel

10. Demand Supply Analysis

11. Value Chain Analysis

12. Porter's Five Forces Analysis

13. PESTLE Analysis

14. Market Dynamics

• 14.1. Market Drivers
• 14.2. Market Challenges

15. Market Trends and Developments

16. Regulatory Framework and Innovation

• 16.1. Regulatory Approvals
• 16.2. Innovations

17. Patent Landscape

18. Case Studies

19. Competitive Landscape

• 19.1. Competition Matrix of Top 5 Market Leaders
• 19.2. SWOT Analysis for Top 5 Players
• 19.3. Key Players Landscape for Top 10 Market Players
  • 19.3.1. Abbott.
    • 19.3.1.1. Company Details
    • 19.3.1.2. Key Management Personnel
    • 19.3.1.3. Products and Services
    • 19.3.1.4. Financials (As Reported)
    • 19.3.1.5. Key Market Focus and Geographical Presence
    • 19.3.1.6. Recent Developments/Collaborations/Partnerships/Mergers and Acquisitions
  • 19.3.2. Bio-Rad Laboratories, Inc.
  • 19.3.3. Trinity Biotech
  • 19.3.4. Siemens Healthineers AG
  • 19.3.5. F.Hoffmann-La Roche Ltd
  • 19.3.6. Danaher Corporation
  • 19.3.7. SAKAE CO, LTD.
  • 19.3.8. ARKRAY, Inc.
  • 19.3.9. HUMAN Gesellschaft fur Biochemica und Diagnostica
  • 19.3.10. Menarini Diagnostics s.r.l

Companies mentioned above DO NOT hold any order as per market share and can be changed as per information available during research work.

20. Strategic Recommendations

21. About Us and Disclaimer